|
SET expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.556900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.532200E-02 |
| Normal-vs-Stage2 |
2.880000E-02 |
| Normal-vs-Stage3 |
1.568810E-04 |
| Normal-vs-Stage4 |
5.742800E-03 |
| Stage1-vs-Stage2 |
2.102600E-01 |
| Stage1-vs-Stage3 |
7.218600E-04 |
| Stage1-vs-Stage4 |
7.790200E-02 |
| Stage2-vs-Stage3 |
2.845400E-01 |
| Stage2-vs-Stage4 |
7.315000E-01 |
| Stage3-vs-Stage4 |
4.454200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.337700E-02 |
| Normal-vs-AfricanAmerican |
1.403170E-04 |
| Normal-vs-Asian |
3.950400E-01 |
| Caucasian-vs-AfricanAmerican |
2.397900E-02 |
| Caucasian-vs-Asian |
9.074400E-01 |
| AfricanAmerican-vs-Asian |
3.109000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.801500E-04 |
| Normal-vs-Female |
1.639590E-01 |
| Male-vs-Female |
4.820700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.771600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.395830E-02 |
| Normal-vs-Age(61-80Yrs) |
8.604900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.815550E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.294400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.300800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.513700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.024000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.652300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.512580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.174400E-01 |
| Normal-vs-Grade 2 |
3.417800E-01 |
| Normal-vs-Grade 3 |
1.74787999999149E-05 |
| Normal-vs-Grade 4 |
2.795600E-03 |
| Grade 1-vs-Grade 2 |
3.369800E-01 |
| Grade 1-vs-Grade 3 |
7.364400E-03 |
| Grade 1-vs-Grade 4 |
6.742100E-02 |
| Grade 2-vs-Grade 3 |
1.76119999995006E-06 |
| Grade 2-vs-Grade 4 |
8.598200E-03 |
| Grade 3-vs-Grade 4 |
8.634400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.797000E-01 |
| Normal-vs-ccB subtype |
4.06270000000708E-05 |
| ccA subtype-vs-ccB subtype |
1.75140000280294E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.879600E-03 |
| Normal-vs-N1 |
6.013800E-01 |
| N0-vs-N1 |
7.192000E-01 |
|
|
